Real-time enrollment status for this relapsed multiple myeloma clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 9:36 AM UTC
| NCT Number | NCT06433947 |
| Recruiting Status | Recruiting |
| Condition | Relapsed Multiple Myeloma |
| Phase | PHASE1 |
| Target Enrollment | 130 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Opna Bio LLC |
| Last Updated on CT.gov | May 19, 2026 (May 19, 2026) |
As of August 27, 2026: Clinical trial NCT06433947 is currently recruiting participants. This phase1 study for relapsed multiple myeloma is actively seeking new participants at 12 locations across the United States. The study is sponsored by Opna Bio LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06433947 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06433947 was last updated May 19, 2026 (May 19, 2026). HelloStudys verifies this status automatically.